Sign in
Taking peopleNo phase

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle

Key facts

Who runs it
Charite University, Berlin, Germany
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
24 people, planned
Started
10 Sept 2025
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • TRE: Time-restricted eating
Record updated
18 September 2025

Who can take part

Age
60 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 35 criteriaShow less

Who can take part

  • Male and female participants, enrolled in a 1:1 ratio
  • Age 60-85 years
  • Body mass index (BMI) 20-35 kg/m²
  • Capacity to give informed consent
  • Existing health insurance to allow evaluation and treatment of any incidental findings
  • Usual daily eating window > 11 hours
  • First meal of the day before 10:00 AM
  • Willingness to receive seasonal influenza and COVID-19 vaccination and proof of scheduled appointment
  • Willingness and ability to follow a prescribed TRE dietary regimen (8-hour daily eating window; 16-hour fast without any caloric intake)
  • Appointment for simultaneous influenza and COVID-19 vaccination pre-arranged with primary care physician and coordinated with study team to align with TRE intervention

Who cannot take part

  • Any vaccination (especially influenza and/or COVID-19) within 6 months before the intervention start
  • History of influenza infection within 6 months prior to initiation of the study intervention
  • History of severe adverse reactions to prior vaccinations
  • Immunosuppression (including use of immunosuppressive drugs)
  • Participation in any fasting intervention (e.g., TRE, alternate-day fasting, 5:2, 18:6) within 6 months before enrollment
  • Antibiotic therapy within 3 months before enrollment
  • Weight change > 2 kg in the month before enrollment
  • Known substance, drug, or alcohol abuse
  • Diabetes mellitus under ongoing pharmacological treatment
  • Symptoms of systemic inflammatory or autoimmune disease
  • Severe hypertension (systolic > 180 mmHg or diastolic > 110 mmHg)
  • Diseases or functional disorders which, in the opinion of the study physician, preclude participation in the study
  • Severe, active, or unstable medical conditions requiring treatment
  • Acute or chronic infections
  • Vaccinations not related to the study, administered during the study period from V0 to V4
  • Use of pharmacological weight-loss agents (e.g., semaglutide)
  • Participation in another diet or weight-loss program (e.g., intensive athletic training)
  • Night-shift or rotating-shift work
  • Postoperative recovery phase
  • Therapeutic or medically prescribed special diets
  • Vegan diet
  • Current smoker
  • Anemia
  • Claustrophobia
  • Legal incapacity or any other circumstance that prevents full understanding of the nature, importance, and implications of the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 60 and 85 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to investigate the effects of a four-week time-restricted eating (TRE) intervention on autophagy, immune function, and vaccine response to a seasonal influenza and COVID-19 vaccines in older healthy subjects.

The 2 groups in the trial

  • Control (no intervention)No study treatment, for comparison

    Four weeks of ad libitum eating pattern with eating time window \>11 h/day. No change of the regular eating pattern.

  • TRETreatment being tested

    Four weeks of TRE, where the daily eating pattern is reduced to 8 h/day. The first meal will be before 10:00 AM.

    Treatment: TRE: Time-restricted eating

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07000708, who can take part
Record updated
18 September 2025